$80.00
IGF-1 LR3 (Insulin-like Growth Factor-1 Long Arg3) is a highly potent synthetic analog of endogenous human IGF-1. Modified with an arginine substitution and a 13-amino acid extension, it effectively evades binding to IGF-binding proteins (IGFBPs). This 1mg format is heavily researched for its profound extended half-life and its capacity to induce severe cellular hyperplasia and accelerated muscle tissue synthesis in laboratory models.
IGF-1 LR3 is a chemically engineered, 83-amino acid analog of human Insulin-like Growth Factor-1. Native IGF-1 plays a primary role in childhood growth and continues to have anabolic effects in adults, mediating many of the functions of Growth Hormone (GH). However, endogenous IGF-1 is rapidly bound by IGF-binding proteins, rendering it inactive with a half-life of roughly 20 minutes. By substituting arginine for glutamic acid at position 3 and adding a 13-amino acid peptide extension at the N-terminus, IGF-1 LR3 bypasses these binding proteins. This modification extends its biological half-life in research models to 20-30 hours, allowing for sustained receptor activation. It is heavily utilized in studies focusing on cellular hyperplasia (the splitting and creation of new cells) rather than mere hypertrophy (cell enlargement).
Technical Specifications
Mechanism of Action (Research Context)
Research into IGF-1 LR3 focuses on its intense anabolic signaling pathways:
Storage and Handling
Testing and Quality Control
Every batch of IGF-1 LR3 1mg undergoes:
Reviews
There are no reviews yet.